Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
FDA Oncology
Apr 28, 2024, 13:23 |
Drugs
Sam Blackman: US FDA approved the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma
Sam Blackman, Co-founder and Chief Medical Officer of Day One Biopharmaceuticals, shared a post by Day…
Apr 26, 2024, 11:10 |
Blog
Vivek Subbiah: The world of oncology converges in Zurich, Switzerland!
Vivek Subbiah posted on X/Twitter: ''The world of oncology converges in Zurich, Switzerland! Such an…
Apr 26, 2024, 11:03 |
Blog
Vivek Subbiah: FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
Vivek Subbiah shared a post on X: "FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive…
Apr 24, 2024, 22:44 |
Blog
Amol Akhade: Can u pronounce name of this latest approved drug by US FDA correctly?
Amol Akhade, Consultant medical oncologist at Suyog Cancer Clinics, shared a post on X: "Can u…
Apr 24, 2024, 17:24 |
Blog
U.S. FDA approved the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma - Day One Biopharmaceuticals
Day One Biopharmaceuticals shared a post on LinkedIn: "Breaking News: Today, we are thrilled to share…
Apr 24, 2024, 09:13 |
Drugs
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…
Apr 23, 2024, 11:34 |
Blog
Vivek Subbiah: What a beautiful venue for a terrific meeting - the Italian Summit of Precision Oncology
Vivek Subbiah shared a post on X: "American Academy of Rome! What a beautiful venue…
Apr 21, 2024, 23:34 |
Blog
Svetlana Nikic: Comprehensive and structured list of FDA-approved CDx NGS assays. Super easy to be found at FDA's website
Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn: "With an overwhelming amount…
Apr 20, 2024, 17:31 |
Blog
The U.S. FDA recently approved two CAR T-cell therapies for earlier treatment of adults with multiple myeloma - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on LinkedIn: "PROGRESS! The U.S. FDA recently approved…
Apr 19, 2024, 20:37 |
Societies
Vivek Subbiah: 4th ESMO webinar of the Precision Oncology series
Vivek Subbiah shared a post by Diogo Martins Branco, Board Member at AICSO, on X/Twitter,…
13
14
15
16
17
All:
562
Posts:
141 - 150
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
World - first lung cancer vaccine trials launched across 7 countries
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Facebook
RSS Feed
Twitter
Linkedin
Youtube